Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital of Wales, Cardiff, CF14 4XW, UK.
Eur Arch Otorhinolaryngol. 2013 May;270(6):1959-65. doi: 10.1007/s00405-013-2345-z. Epub 2013 Jan 12.
Tonsillectomy is a common therapeutic option in the management of recurrent tonsillitis. In 1999, the Scottish Intercollegiate Guidelines Network (SIGN) introduced SIGN 34 outlining appropriate indications for tonsillectomy. Following concerns of increasing hospital admissions for tonsillitis, in 2009 ENT UK suggested that too few tonsillectomies were being undertaken. This study analyses the effect the SIGN guidelines have had on trends in population rates of tonsillectomy and hospital admissions for tonsillitis and peritonsillar abscess in England, Scotland and Wales. A retrospective study was undertaken using the health databases of England, Scotland and Wales between 1999 and 2010. Tonsillectomy, acute tonsillitis and peritonsillar abscess were identified using national classification codes. Changes in rate of tonsillectomy and hospital admissions for tonsillitis and peritonsillar abscess were assessed using a linear regression model. 699,898 tonsillectomies were undertaken in the three national cohorts over the study period. Linear regression analysis suggested that implementation of SIGN 34 significantly reduced the population rate of tonsillectomy in England (p = 0.005) and Wales (p = 0.003) but not in Scotland (p = 0.24), and indicated there had been an increase in hospital admissions for acute tonsillitis in all cohorts (England p = 0.000008, Scotland p = 0.03, Wales p = 0.000005) and peritonsillar abscess in England (p < 0.05) and Wales (p = 0.03). SIGN 34 has reduced tonsillectomy rates in England and Wales but not in Scotland. This finding is associated with increasing hospital admissions for acute tonsillitis in all national cohorts, which may suggest that the current stipulated guidelines miss patients who would benefit from surgical intervention.
扁桃体切除术是治疗复发性扁桃体炎的常用治疗选择。1999 年,苏格兰校际指南网 (SIGN) 发布了 SIGN 34,其中概述了扁桃体切除术的适当适应证。由于对因扁桃体炎而住院人数增加的担忧,2009 年 ENT UK 建议进行的扁桃体切除术太少。本研究分析了 SIGN 指南对英格兰、苏格兰和威尔士人群扁桃体切除术和扁桃体炎及扁桃体周脓肿住院率趋势的影响。该研究使用了英格兰、苏格兰和威尔士的健康数据库,对 1999 年至 2010 年期间的数据进行了回顾性研究。扁桃体切除术、急性扁桃体炎和扁桃体周脓肿使用国家分类代码进行识别。采用线性回归模型评估扁桃体切除术和扁桃体炎及扁桃体周脓肿住院率的变化。在研究期间,三个国家队列共进行了 699898 例扁桃体切除术。线性回归分析表明,SIGN 34 的实施显著降低了英格兰 (p = 0.005) 和威尔士 (p = 0.003) 的人群扁桃体切除术率,但在苏格兰则不然 (p = 0.24),并且表明所有队列的急性扁桃体炎住院人数均有所增加 (英格兰 p = 0.000008,苏格兰 p = 0.03,威尔士 p = 0.000005) 以及英格兰 (p < 0.05) 和威尔士 (p = 0.03) 的扁桃体周脓肿。SIGN 34 降低了英格兰和威尔士的扁桃体切除术率,但在苏格兰则不然。这一发现与所有国家队列中因急性扁桃体炎而住院的人数增加有关,这可能表明目前规定的指南遗漏了需要手术干预的患者。